These effects, together with a preceding report displaying that a little-molecule ACKR3 agonist CCX771 displays anxiolytic-like behavior in mice,2 help the strategy of targeting ACKR3 as a unique approach to modulate the opioid system, which could open up new therapeutic avenues for opioid-associated Ailments. Continual pain is advanced, and https://waltery950rjz6.iyublog.com/profile